Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- Check4 days agoChange DetectedA new version entry dated 2026-05-15 with added Contacts/Locations and Study Status sections was added to the history, and the 2026-05-01 entry was removed.SummaryDifference0.2%

- Check11 days agoChange DetectedA new revision entry v3.5.4 has been added to the record history. The previous revision v3.5.3 was removed.SummaryDifference0.0%

- Check18 days agoChange DetectedNew entries were added to the study history for the version on 2026-05-01, introducing Contacts/Locations and Study Status updates (with a related 2026-04-30 entry). A prior version dated 2026-04-17 was deleted from the history.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe record history view shows an updated latest version entry dated 2026-04-16/2026-04-17, with changes categorized under Study Status and Contacts/Locations. It also reflects a UI/app revision update (v3.5.3) and removes an older revision reference (v3.5.2) from the history list.SummaryDifference0.2%

- Check40 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the 2026-04-03 update; 2026-03-20 content was deleted.SummaryDifference0.2%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.